Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-87.49%Return on Equity
VS
Market
Sector
Industry
History
$ 0.39Close
$ 0.23 - $ 1.32 52-Week Range
Ticker Information
Ticker
CODXCompany Name
CO-DIAGNOSTICS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQCO-DIAGNOSTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CODX - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 41.14M | $ -35.99M | -87.49% |
| 3/31/2025 | $ 47.92M | $ -35.86M | -74.83% |
| 12/31/2024 | $ 54.31M | $ -37.64M | -69.3% |
| 9/30/2024 | $ 63.78M | $ -41.28M | -64.73% |
| 6/30/2024 | $ 72.4M | $ -37.57M | -51.89% |
| 3/31/2024 | $ 78.35M | $ -38.89M | -49.63% |
| 12/31/2023 | $ 86.01M | $ -35.33M | -41.08% |
| 9/30/2023 | $ 99.49M | $ -42.56M | -42.78% |
| 6/30/2023 | $ 103.43M | $ -37.94M | -36.68% |
| 3/31/2023 | $ 110.63M | $ -31.71M | -28.66% |
Key Performance Insights, Last 5 Years
- CO-DIAGNOSTICS INC's latest trailing twelve months (TTM) ROE stands at 52.93%.
- Over the past 5 years, CO-DIAGNOSTICS INC's average ROE has been -9.76%.
- The median ROE for CO-DIAGNOSTICS INC during this period was -20.55%
- CO-DIAGNOSTICS INC reached its highest ROE over the past 5 years at 67.46%.
- The lowest ROE recorded by CO-DIAGNOSTICS INC in the same timeframe -87.49%
CO-DIAGNOSTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for CO-DIAGNOSTICS INC is calculated as follows: Net Inc. Cmn. [ $ 27.94M ] / Equity [ $ 52.78M ]
(=) ROE [ 52.93% ] CODX - Return on Equity, Last 5 years
-87.49%
Minimum
Jun 30, 2025
67.46%
Maximum
Mar 31, 2021
-9.76%
Average
-20.55%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |